7 results
8-K
EX-99
INVA
Innoviva Inc
8 Dec 06
Other Events
12:00am
of the bacterial cell membrane."
"The submission of the telavancin NDA is an important milestone in the history of Theravance and advances our mission to create
8-K
EX-99.1
INVA
Innoviva Inc
11 Jul 22
Innoviva to Acquire La Jolla Pharmaceutical Company
7:38am
continue to advance our mission and maximize the potential of our innovative therapies.”
Assuming the minimum tender condition is met, any shares
SC TO-C
EX-99.1
INVA
Innoviva Inc
11 Jul 22
Information about tender offer
3:46pm
continue to advance our mission and maximize the potential of our innovative therapies.”
Assuming the minimum tender condition is met, any shares
425
LJPC
La Jolla Pharmaceutical Co.
11 Jul 22
Business combination disclosure
7:38am
of Gibson, Dunn & Crutcher, LLP, 555 Mission Street, Suite 3000, San Francisco, California 94105, or such other location or means as shall be mutually agreed … -mail: ktang@ljpc.com
with a copy (which shall not constitute notice) to:
Gibson, Dunn & Crutcher LLP
555 Mission Street, Suite 3000
San Francisco
8-K
EX-2.1
INVA
Innoviva Inc
11 Jul 22
Innoviva to Acquire La Jolla Pharmaceutical Company
7:38am
(the “Closing”) shall take place at the offices of Gibson, Dunn & Crutcher, LLP, 555 Mission Street, Suite 3000, San Francisco, California 94105 … Mission Street, Suite 3000
San Francisco, California 94105
Attention: Ryan A. Murr and Branden C. Berns
E-mail: RMurr@gibsondunn.com; Bberns
SC TO-C
EX-2.1
rn8djuabadh z4sjb
11 Jul 22
Information about tender offer
3:46pm
- Prev
- 1
- Next